Can a simple conversation prevent deadly blood clots?
NCT ID NCT06731244
First seen Jan 05, 2026 · Last updated Jun 23, 2026 · Updated 31 times
Summary
This study tests whether a shared decision-making process, which uses personalized risk scores, can help patients with unprovoked blood clots choose the best duration of blood-thinning medication. The goal is to reduce the chance of another clot or serious bleeding while improving patient satisfaction. About 2,400 adults who have had a first unprovoked clot will be randomly assigned to usual care or the shared decision-making approach.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
APHM - Hôpital la Timone
NOT_YET_RECRUITINGMarseille, 13005, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
APHP-Colombes
NOT_YET_RECRUITINGColombes, 92700, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Aphp-Hegp
NOT_YET_RECRUITINGParis, 75015, France
-
Aphp-Hegp
NOT_YET_RECRUITINGParis, 75015, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CH Le Mans
NOT_YET_RECRUITINGLe Mans, 72037, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Brest
RECRUITINGBrest, France, 29609, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Saint Etienne
NOT_YET_RECRUITINGSaint-Etienne, 42270 Saint Priest En Jarez, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU d'Amiens - Picardie
NOT_YET_RECRUITINGAmiens, 80054, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU d'Angers
NOT_YET_RECRUITINGAngers, 49933, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Clermont Ferrand
NOT_YET_RECRUITINGClermont-Ferrand, 63000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Dijon - Hôpital François Mitterand
NOT_YET_RECRUITINGDijon, 21079, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Montpellier
NOT_YET_RECRUITINGMontpellier, 34295, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Nancy
NOT_YET_RECRUITINGNancy, 54511, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Nantes
NOT_YET_RECRUITINGNantes, 44093, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Nîmes
NOT_YET_RECRUITINGNîmes, 30029, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Rennes
NOT_YET_RECRUITINGRennes, 35200, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Strasbourg
NOT_YET_RECRUITINGStrasbourg, 67091, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Toulouse
NOT_YET_RECRUITINGToulouse, 31000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
HCL - Hôpital Edouard Herriot
NOT_YET_RECRUITINGLyon, 69003, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital National d'Instruction des Armées Percy
NOT_YET_RECRUITINGClamart, 92140, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
shared decision-making process
What this could lead to
If successful, this approach could help patients and doctors choose the right duration of blood-thinning therapy, reducing the risk of another clot or serious bleeding.
What could go wrong
This is a large but early-stage study testing a decision-making process, not a drug. The results may not change current practice if the intervention does not clearly improve outcomes.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.